top of page

Clinical Research

Along with normal clinical service,  wide range of clinical trials also provided in our center

We are actively recruiting patient to participate in the following clinical trials

Please send referral letter to  if interested

Recruiting clinical Trials 

Breast Cancer

Protocol Number

Protocol Title

Experimental agent

Principle Investigator


The GLORIA Study: A Phase 3, Randomized, Open-Label Study of the Anti-Globo H Vaccine Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients with High-Risk, Early-Stage Globo H-Positive Triple Negative Breast Cancer

OBI-822, OBI-821



​​GS-US-592-6173 (Ascent -04)

A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer, Whose Tumors Express PD-L1

Sacituzumab Govitecan-hziy (SG) + Pembrolizumab


Pembrolizumab + Treatment of Physician's Choice (TPC)


A Phase 2 Study of Magrolimab Combination Therapy in Patients With Unresectable, Locally Advanced or Metastatic Triple-Negative Breast Cancer

Magrolimab + Nab-Paclitaxel or Paclitaxe


Nab-Paclitaxel or Paclitaxe

bottom of page